Literature DB >> 31088844

A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.

Joseph Cursons1,2, Fernando Souza-Fonseca-Guimaraes2,3, Nicholas D Huntington4,3,5, Melissa J Davis6,2,7, Momeneh Foroutan1,8, Ashley Anderson1, Frédéric Hollande8, Soroor Hediyeh-Zadeh1, Andreas Behren9,10.   

Abstract

Natural killer (NK) cell activity is essential for initiating antitumor responses and may be linked to immunotherapy success. NK cells and other innate immune components could be exploitable for cancer treatment, which drives the need for tools and methods that identify therapeutic avenues. Here, we extend our gene-set scoring method singscore to investigate NK cell infiltration by applying RNA-seq analysis to samples from bulk tumors. Computational methods have been developed for the deconvolution of immune cell types within solid tumors. We have taken the NK cell gene signatures from several such tools, then curated the gene list using a comparative analysis of tumors and immune cell types. Using a gene-set scoring method to investigate RNA-seq data from The Cancer Genome Atlas (TCGA), we show that patients with metastatic cutaneous melanoma have an improved survival rate if their tumor shows evidence of NK cell infiltration. Furthermore, these survival effects are enhanced in tumors that show higher expression of genes that encode NK cell stimuli such as the cytokine IL15 Using this signature, we then examine transcriptomic data to identify tumor and stromal components that may influence the penetrance of NK cells into solid tumors. Our results provide evidence that NK cells play a role in the regulation of human tumors and highlight potential survival effects associated with increased NK cell activity. Our computational analysis identifies putative gene targets that may be of therapeutic value for boosting NK cell antitumor immunity. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31088844     DOI: 10.1158/2326-6066.CIR-18-0500

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  76 in total

1.  Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer.

Authors:  Damien J Zanker; Katie L Owen; Nikola Baschuk; Alex J Spurling; Belinda S Parker
Journal:  Cancer Immunol Immunother       Date:  2021-01-15       Impact factor: 6.968

Review 2.  The cancer-natural killer cell immunity cycle.

Authors:  Nicholas D Huntington; Joseph Cursons; Jai Rautela
Journal:  Nat Rev Cancer       Date:  2020-06-24       Impact factor: 60.716

Review 3.  Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion.

Authors:  Suchit Jhunjhunwala; Christian Hammer; Lélia Delamarre
Journal:  Nat Rev Cancer       Date:  2021-03-09       Impact factor: 60.716

Review 4.  Tumor-Infiltrating Natural Killer Cells.

Authors:  Beatriz Cózar; Marco Greppi; Sabrina Carpentier; Emilie Narni-Mancinelli; Laura Chiossone; Eric Vivier
Journal:  Cancer Discov       Date:  2020-12-04       Impact factor: 39.397

5.  Protein Signatures of NK Cell-Mediated Melanoma Killing Predict Response to Immunotherapies.

Authors:  Sabrina Cappello; Hsu-Min Sung; Christian Ickes; Christine S Gibhardt; Adina Vultur; Hilal Bhat; Zhongwen Hu; Patricia Brafford; Andreas Denger; Ioana Stejerean-Todoran; Rixa-Mareike Köhn; Verena Lorenz; Nicolas Künzel; Gabriela Salinas; Hedwig Stanisz; Tobias Legler; Peter Rehling; Michael P Schön; Karl S Lang; Volkhard Helms; Meenhard Herlyn; Markus Hoth; Carsten Kummerow; Ivan Bogeski
Journal:  Cancer Res       Date:  2021-09-13       Impact factor: 12.701

6.  The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Authors:  Susanna S Ng; Fabian De Labastida Rivera; Juming Yan; Dillon Corvino; Indrajit Das; Ping Zhang; Rachel Kuns; Shashi Bhushan Chauhan; Jiajie Hou; Xian-Yang Li; Teija C M Frame; Benjamin A McEnroe; Eilish Moore; Jinrui Na; Jessica A Engel; Megan S F Soon; Bhawana Singh; Andrew J Kueh; Marco J Herold; Marcela Montes de Oca; Siddharth Sankar Singh; Patrick T Bunn; Amy Roman Aguilera; Mika Casey; Matthias Braun; Nazanin Ghazanfari; Shivangi Wani; Yulin Wang; Fiona H Amante; Chelsea L Edwards; Ashraful Haque; William C Dougall; Om Prakash Singh; Alan G Baxter; Michele W L Teng; Alex Loukas; Norelle L Daly; Nicole Cloonan; Mariapia A Degli-Esposti; Jude Uzonna; William R Heath; Tobias Bald; Siok-Keen Tey; Kyohei Nakamura; Geoffrey R Hill; Rajiv Kumar; Shyam Sundar; Mark J Smyth; Christian R Engwerda
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 25.606

7.  Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells.

Authors:  Ying Yang; Shi Yong Neo; Ziqing Chen; Weiyingqi Cui; Yi Chen; Min Guo; Yongfang Wang; Haiyan Xu; Annina Kurzay; Evren Alici; Lars Holmgren; Felix Haglund; Kai Wang; Andreas Lundqvist
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 8.  Targeting the epigenetic regulation of antitumour immunity.

Authors:  Simon J Hogg; Paul A Beavis; Mark A Dawson; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2020-09-14       Impact factor: 84.694

Review 9.  The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Authors:  Tobias Bald; Matthew F Krummel; Mark J Smyth; Kevin C Barry
Journal:  Nat Immunol       Date:  2020-07-20       Impact factor: 25.606

10.  Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.

Authors:  Yuan Yuan; Zheng Zhu; Ying Lan; Saili Duan; Ziqing Zhu; Xi Zhang; Guoyin Li; Hui Qu; Yanhui Feng; Hui Cai; Zewen Song
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.